The latest episode of STAT's "The Readout LOUD" podcast opens with a conversation about a troubling trend: Americans' declining trust in science. The hosts bring on STAT's new trust-in-science reporter Nicholas Florko to discuss how policy leaders have fueled that skepticism, framing it as a backdrop for the week's biotech news.
Among the items covered are a clinical update from UniQure on its gene therapy for Huntington's disease, and a lawsuit filed by Beam Therapeutics against a Chinese competitor in the gene-editing space. The episode summary does not provide details on the nature of the update or the lawsuit's claims, only that they were discussed.
The podcast also notes a shift in how pharma companies such as Novo Nordisk and Eli Lilly are talking about their GLP-1 products. This suggests a change in messaging around obesity treatments, though specifics are not given in the summary.
Because the source is a podcast description, these items are presented as topics of discussion rather than in-depth analyses. They are distinct stories that happen to be grouped in a single episode.